Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Tumor cell MT1-MMP is dispensable for osteosarcoma tumor growth, bone degradation and lung metastasis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Biochemical abnormalities among patients referred for celiac disease antibody blood testing in a primary health care setting

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Reduced levels of pulmonary surfactant in COVID-19 ARDS

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Chronic inflammation markers and cytokine-specific autoantibodies in Danish blood donors with restless legs syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Assessment of immunogenicity and drug activity in patient sera by flow-induced dispersion analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Deep learning for Dixon MRI-based attenuation correction in PET/MRI of head and neck cancer patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Sex Differences and Caffeine Impact in Adenosine-Induced Hyperemia

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The membrane-anchored matrix metalloprotease MT1-MMP is a potent collagenolytic enzyme with a well-established role in extracellular matrix turnover and cellular invasion into collagen-rich tissues. MT1-MMP is highly expressed in various types of cancer and has been demonstrated to be directly involved in several stages of tumor progression, including primary tumor growth, angiogenesis, invasion and metastasis. Osteosarcoma is the most common type of primary bone cancer. This disease is characterized by invasive tumor growth, leading to extensive bone destruction, and metastasis to the lungs. The tumor cells in human osteosarcoma display a strong expression of MT1-MMP, but the role of MT1-MMP in osteosarcoma progression is currently unknown. In this study, we investigated the role of MT1-MMP during various stages of osteosarcoma development. We utilized an optimized orthotopic murine osteosarcoma model and human osteosarcoma cells in which the MT1-MMP gene was knocked out using CRISPR/Cas9. We observed a strong expression of MT1-MMP in wildtype cells of both primary tumors and lung metastases, but, surprisingly, MT1-MMP deficiency did not affect primary tumor growth, bone degradation or the formation and growth of lung metastases. We therefore propose that, unlike findings reported in other cancers, tumor-expressed MT1-MMP is dispensable for all stages of osteosarcoma progression.

Original languageEnglish
Article number19138
JournalScientific Reports
Volume10
Issue number1
Pages (from-to)19138
ISSN2045-2322
DOIs
Publication statusPublished - 5 Nov 2020

ID: 61301596